Tomita et al[28] demonstrated that the existence of CDCA1-specific Th cell responses in HNSCC patients underline the potential utility of CDCA1-LPs for propagation of both CDCA1-specific CTLs and Th cells. The gene discussed is NUF2; the disease is head and neck squamous cell carcinoma.